{
"NDC": {
"NDCCode": "31722-627-46",
"PackageDescription": "1 BOTTLE in 1 CARTON (31722-627-46) / 465 mL in 1 BOTTLE",
"NDC11Code": "31722-0627-46",
"ProductNDC": "31722-627",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Lacosamide",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Lacosamide",
"DosageFormName": "SOLUTION",
"RouteName": "ORAL",
"StartMarketingDate": "20220531",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA209301",
"LabelerName": "Camber Pharmaceuticals, Inc.",
"SubstanceName": "LACOSAMIDE",
"StrengthNumber": "10",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
"DEASchedule": "CV",
"Status": "Active",
"LastUpdate": "2025-09-30",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20220531",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}